Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Management of ocular sarcoidosis.

Baughman RP, Lower EE, Ingledue R, Kaufman AH.

Sarcoidosis Vasc Diffuse Lung Dis. 2012 Mar;29(1):26-33.

PMID:
23311120
2.

Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.

Riancho-Zarrabeitia L, Calvo-Río V, Blanco R, Mesquida M, Adan AM, Herreras JM, Aparicio Á, Peiteado-Lopez D, Cordero-Coma M, García Serrano JL, Ortego-Centeno N, Maíz O, Blanco A, Sánchez-Bursón J, González-Suárez S, Fonollosa A, Santos-Gómez M, González-Vela C, Loricera J, Pina T, González-Gay MA.

Semin Arthritis Rheum. 2015 Dec;45(3):361-8. doi: 10.1016/j.semarthrit.2015.05.010. Epub 2015 May 21.

PMID:
26092330
3.

Leflunomide for chronic sarcoidosis.

Baughman RP, Lower EE.

Sarcoidosis Vasc Diffuse Lung Dis. 2004 Mar;21(1):43-8.

PMID:
15127974
4.

Infliximab in chronic ocular inflammation.

Baughman RP, Bradley DA, Lower EE.

Int J Clin Pharmacol Ther. 2005 Jan;43(1):7-11.

PMID:
15704608
5.
6.

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.

Weisman MH, Moreland LW, Furst DE, Weinblatt ME, Keystone EC, Paulus HE, Teoh LS, Velagapudi RB, Noertersheuser PA, Granneman GR, Fischkoff SA, Chartash EK.

Clin Ther. 2003 Jun;25(6):1700-21.

PMID:
12860493
7.

Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.

Absah I, Faubion WA Jr.

Inflamm Bowel Dis. 2012 Aug;18(8):1488-92. doi: 10.1002/ibd.21885. Epub 2011 Aug 31.

PMID:
21882301
8.

Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.

Strangfeld A, Hierse F, Kekow J, von Hinueber U, Tony HP, Dockhorn R, Listing J, Zink A.

Ann Rheum Dis. 2009 Dec;68(12):1856-62. doi: 10.1136/ard.2008.098467. Epub 2009 Jan 6.

PMID:
19126559
9.

Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.

Russell E, Luk F, Manocha S, Ho T, O'Connor C, Hussain H.

Semin Arthritis Rheum. 2013 Aug;43(1):119-24. doi: 10.1016/j.semarthrit.2012.10.008. Epub 2013 Jan 16.

PMID:
23332903
11.

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.

Barrera P, van der Maas A, van Ede AE, Kiemeney BA, Laan RF, van de Putte LB, van Riel PL.

Rheumatology (Oxford). 2002 Apr;41(4):430-9.

PMID:
11961174
12.

T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.

Deepak P, Sifuentes H, Sherid M, Stobaugh D, Sadozai Y, Ehrenpreis ED.

Am J Gastroenterol. 2013 Jan;108(1):99-105. doi: 10.1038/ajg.2012.334. Epub 2012 Oct 2.

PMID:
23032984
13.

Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: a real life cohort study.

Ma C, Huang V, Fedorak DK, Kroeker KI, Dieleman LA, Halloran BP, Fedorak RN.

J Crohns Colitis. 2014 Nov;8(11):1454-63. doi: 10.1016/j.crohns.2014.05.007. Epub 2014 Jun 16.

PMID:
24947334
14.

Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone.

Visvanathan S, Keenan GF, Baker DG, Levinson AI, Wagner CL.

J Rheumatol. 2007 May;34(5):952-7. Epub 2007 Apr 15.

PMID:
17444589
15.

Sarcoidosis: an update on current pharmacotherapy options and future directions.

Brito-Zerón P, Pérez-Alvarez R, Pallarés L, Retamozo S, Baughman RP, Ramos-Casals M; SarcoGEAS-SEMI Study Group.

Expert Opin Pharmacother. 2016 Dec;17(18):2431-2448. Review.

PMID:
27817209
16.

Refractory sarcoidosis responding to infliximab.

Roberts SD, Wilkes DS, Burgett RA, Knox KS.

Chest. 2003 Nov;124(5):2028-31.

PMID:
14605086
17.

Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.

Schmidt J, Kermani TA, Bacani AK, Crowson CS, Matteson EL, Warrington KJ.

Arthritis Care Res (Hoboken). 2012 Jul;64(7):1079-83. doi: 10.1002/acr.21636.

18.

Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.

Molloy ES, Langford CA, Clark TM, Gota CE, Hoffman GS.

Ann Rheum Dis. 2008 Nov;67(11):1567-9. doi: 10.1136/ard.2008.093260. Epub 2008 Aug 3.

PMID:
18677012
19.

Adalimumab in the therapy of uveitis in childhood.

Biester S, Deuter C, Michels H, Haefner R, Kuemmerle-Deschner J, Doycheva D, Zierhut M.

Br J Ophthalmol. 2007 Mar;91(3):319-24. Epub 2006 Oct 11.

20.

Anti-TNF-α therapy in the management of severe neurosarcoidosis: a report of five cases from a single centre and literature review.

Riancho-Zarrabeitia L, Delgado-Alvarado M, Riancho J, Oterino A, Sedano MJ, Rueda-Gotor J, Pérez-Martín I, González-Vela MC, Berciano J, González-Gay MA, Blanco R.

Clin Exp Rheumatol. 2014 Mar-Apr;32(2):275-84. Epub 2013 Dec 9. Review.

PMID:
24321604

Supplemental Content

Support Center